G

GKB Ophthalmics Ltd
BSE:533212

Watchlist Manager
GKB Ophthalmics Ltd
BSE:533212
Watchlist
Price: 99 INR 1.1% Market Closed
Market Cap: 499m INR
Have any thoughts about
GKB Ophthalmics Ltd?
Write Note
Section:
 

Relative Value

533212 doesn't have a meaningful market cap.

The Relative Value of one GKB stock under the Base Case scenario is 189.41 INR. Compared to the current market price of 99 INR, GKB Ophthalmics Ltd is Undervalued by 48%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

GKB Relative Value
Base Case
189.41 INR
Undervaluation 48%
Relative Value
Price
G
Worst Case
Base Case
Best Case

Valuation Multiples

0.5
P/S
P/S
Price to Sales
0.5
vs History
85
vs Industry
76
Median 3Y
0.6
Median 5Y
0.6
Industry
2.3
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
26
Median 3Y
-13.4
Median 5Y
-13.4
Industry
23
More Details
20.6
P/OCF
P/OCF
Price to OCF
20.6
vs History
20
vs Industry
30
Median 3Y
13.7
Median 5Y
9.4
Industry
14.3
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
3
Median 3Y
-22.6
Median 5Y
-21.7
Industry
20
More Details
0.9
P/B
P/B
Price to Book Value
0.9
vs History
15
vs Industry
66
Median 3Y
0.8
Median 5Y
0.7
Industry
2.2
More Details
0.5
EV/S
EV/S
Enterprise Value to Sales
0.5
vs History
84
vs Industry
77
Median 3Y
0.7
Median 5Y
0.7
Industry
2.4
More Details
1.6
EV/GP
EV/GP
Enterprise Value to Gross Profit
1.6
vs History
79
vs Industry
70
Median 3Y
1.9
Median 5Y
1.9
Industry
5
More Details
97
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
97
vs History
14
vs Industry
2
Median 3Y
16.3
Median 5Y
16
Industry
12.9
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
5
Median 3Y
-6.6
Median 5Y
-10.8
Industry
17.4
More Details
20.2
EV/OCF
EV/OCF
Enterprise Value to OCF
20.2
vs History
12
vs Industry
31
Median 3Y
13.9
Median 5Y
10.2
Industry
14
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
20
Median 3Y
-13.3
Median 5Y
-16
Industry
18.2
More Details
0.6
EV/IC
EV/IC
Enterprise Value to IC
0.6
vs History
41
vs Industry
71
Median 3Y
0.7
Median 5Y
0.6
Industry
1.9
More Details

Multiples Across Competitors

GKB Competitors Multiples
GKB Ophthalmics Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IN
GKB Ophthalmics Ltd
BSE:533212
493.6m INR 0.5 -13.7 97 -19.8
JP
Hoya Corp
TSE:7741
7T JPY 8.5 35.6 23.9 28.8
CH
Alcon AG
SIX:ALC
37.8B CHF 4.2 35.7 17.6 34.1
DK
Coloplast A/S
CSE:COLO B
178.8B DKK 6.6 35.5 22.8 26.8
US
Align Technology Inc
NASDAQ:ALGN
16.1B USD 4.1 36.4 18.4 22.1
KR
HLB Inc
KOSDAQ:028300
10.5T KRW 202.1 -56.5 -87 -82.1
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
51.1B CNY 11.5 27.6 24 24
US
Lantheus Holdings Inc
NASDAQ:LNTH
6.5B USD 4.4 15.3 10.6 12
CA
Bausch + Lomb Corp
NYSE:BLCO
6.4B USD 1.4 -17.3 16.7 56
US
Merit Medical Systems Inc
NASDAQ:MMSI
5.7B USD 4.3 47.6 23.7 38.9
UK
ConvaTec Group PLC
LSE:CTEC
4.6B GBP 2.6 37.2 264.5 462.1
P/E Multiple
Earnings Growth PEG
IN
G
GKB Ophthalmics Ltd
BSE:533212
Average P/E: 33.9
Negative Multiple: -13.7 		N/A N/A
JP
Hoya Corp
TSE:7741
35.6
15%
2.4
CH
Alcon AG
SIX:ALC
35.7
27%
1.3
DK
Coloplast A/S
CSE:COLO B
35.5
15%
2.4
US
Align Technology Inc
NASDAQ:ALGN
36.4
26%
1.4
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -56.5 N/A N/A
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
27.6
24%
1.1
US
Lantheus Holdings Inc
NASDAQ:LNTH
15.3
19%
0.8
CA
Bausch + Lomb Corp
NYSE:BLCO
Negative Multiple: -17.3 N/A N/A
US
Merit Medical Systems Inc
NASDAQ:MMSI
47.6
37%
1.3
UK
ConvaTec Group PLC
LSE:CTEC
37.2
46%
0.8
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
IN
G
GKB Ophthalmics Ltd
BSE:533212
Average EV/EBIT: 78.3
Negative Multiple: -19.8 		N/A N/A
JP
Hoya Corp
TSE:7741
28.8
N/A N/A
CH
Alcon AG
SIX:ALC
34.1
27%
1.3
DK
Coloplast A/S
CSE:COLO B
26.8
12%
2.2
US
Align Technology Inc
NASDAQ:ALGN
22.1
17%
1.3
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -82.1 N/A N/A
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
24
23%
1
US
Lantheus Holdings Inc
NASDAQ:LNTH
12
12%
1
CA
Bausch + Lomb Corp
NYSE:BLCO
56
56%
1
US
Merit Medical Systems Inc
NASDAQ:MMSI
38.9
36%
1.1
UK
ConvaTec Group PLC
LSE:CTEC
462.1
25%
18.5

See Also

Summary
GKB intrinsic value, competitors valuation, and company profile.
DCF Valuation
GKB stock valuation using Discount Cash Flow valuation method.
Relative Valuation
GKB stock valuation using valuation multiples.
Wall Street Estimates
GKB price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
GKB stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 215,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.